Geoffrey Beran Rose

CIK: 0001804146

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)37 (94.9%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (5.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LUNG

Pulmonx Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (39 total)

LUNG
Pulmonx Corp
Sep 1, 2026
Sale(S)
Direct
1.7K shares at avg. $2.26$4K
LUNG
Pulmonx Corp
Sep 1, 2026
Sale(S)
Direct
1.5K shares at avg. $2.26$3K
LUNG
Pulmonx Corp
Sep 1, 2026
Sale(S)
Direct
2.4K shares at avg. $2.26$5K
LUNG
Pulmonx Corp
Sep 1, 2026
Sale(S)
Direct
2.2K shares at avg. $2.26$5K
LUNG
Pulmonx Corp
Jun 1, 2026
Sale(S)
Direct
1.8K shares at avg. $1.54$3K
LUNG
Pulmonx Corp
Jun 1, 2026
Sale(S)
Direct
1.6K shares at avg. $1.54$2K
LUNG
Pulmonx Corp
Jun 1, 2026
Sale(S)
Direct
2.4K shares at avg. $1.54$4K
LUNG
Pulmonx Corp
Jun 1, 2026
Sale(S)
Direct
2.3K shares at avg. $1.54$3K
LUNG
Pulmonx Corp
Mar 2, 2026
Award(A)
Direct
100K shares-
LUNG
Pulmonx Corp
Mar 2, 2026
Sale(S)
Direct
2.9K shares at avg. $1.43$4K
LUNG
Pulmonx Corp
Mar 2, 2026
Sale(S)
Direct
1.9K shares at avg. $1.43$3K
LUNG
Pulmonx Corp
Mar 2, 2026
Sale(S)
Direct
2.1K shares at avg. $1.43$3K
LUNG
Pulmonx Corp
Mar 2, 2026
Sale(S)
Direct
835 shares at avg. $1.43$1K
LUNG
Pulmonx Corp
Dec 1, 2025
Sale(S)
Direct
1.7K shares at avg. $1.57$3K
LUNG
Pulmonx Corp
Dec 1, 2025
Sale(S)
Direct
2.4K shares at avg. $1.57$4K
LUNG
Pulmonx Corp
Dec 1, 2025
Sale(S)
Direct
1.5K shares at avg. $1.57$2K
LUNG
Pulmonx Corp
Dec 1, 2025
Sale(S)
Direct
683 shares at avg. $1.57$1K
LUNG
Pulmonx Corp
Sep 2, 2025
Sale(S)
Direct
707 shares at avg. $1.60$1K
LUNG
Pulmonx Corp
Sep 2, 2025
Sale(S)
Direct
2.5K shares at avg. $1.60$4K
LUNG
Pulmonx Corp
Sep 2, 2025
Sale(S)
Direct
1.6K shares at avg. $1.60$3K
LUNG
Pulmonx Corp
Sep 2, 2025
Sale(S)
Direct
1.8K shares at avg. $1.60$3K
LUNG
Pulmonx Corp
Jun 2, 2025
Sale(S)
Direct
708 shares at avg. $3.13$2K
LUNG
Pulmonx Corp
Jun 2, 2025
Sale(S)
Direct
1.8K shares at avg. $3.13$6K
LUNG
Pulmonx Corp
Jun 2, 2025
Sale(S)
Direct
401 shares at avg. $3.14$1K
LUNG
Pulmonx Corp
Jun 2, 2025
Sale(S)
Direct
1.6K shares at avg. $3.13$5K

		Type	Shares	Price		Ownership
Sep 1, 2026	LUNG Pulmonx Corp	Sale(S)	1,746	$2.26	$3,946	Direct
Sep 1, 2026	LUNG Pulmonx Corp	Sale(S)	1,530	$2.26	$3,458	Direct
Sep 1, 2026	LUNG Pulmonx Corp	Sale(S)	2,390	$2.26	$5,401	Direct
Sep 1, 2026	LUNG Pulmonx Corp	Sale(S)	2,213	$2.26	$5,001	Direct
Jun 1, 2026	LUNG Pulmonx Corp	Sale(S)	1,778	$1.54	$2,738	Direct
Jun 1, 2026	LUNG Pulmonx Corp	Sale(S)	1,557	$1.54	$2,398	Direct
Jun 1, 2026	LUNG Pulmonx Corp	Sale(S)	2,434	$1.54	$3,748	Direct
Jun 1, 2026	LUNG Pulmonx Corp	Sale(S)	2,254	$1.54	$3,471	Direct
Mar 2, 2026	LUNG Pulmonx Corp	Award(A)	100,000	-	$0	Direct
Mar 2, 2026	LUNG Pulmonx Corp	Sale(S)	2,911	$1.43	$4,163	Direct
Mar 2, 2026	LUNG Pulmonx Corp	Sale(S)	1,861	$1.43	$2,661	Direct
Mar 2, 2026	LUNG Pulmonx Corp	Sale(S)	2,125	$1.43	$3,039	Direct
Mar 2, 2026	LUNG Pulmonx Corp	Sale(S)	835	$1.43	$1,194	Direct
Dec 1, 2025	LUNG Pulmonx Corp	Sale(S)	1,738	$1.57	$2,729	Direct
Dec 1, 2025	LUNG Pulmonx Corp	Sale(S)	2,379	$1.57	$3,735	Direct
Dec 1, 2025	LUNG Pulmonx Corp	Sale(S)	1,522	$1.57	$2,390	Direct
Dec 1, 2025	LUNG Pulmonx Corp	Sale(S)	683	$1.57	$1,072	Direct
Sep 2, 2025	LUNG Pulmonx Corp	Sale(S)	707	$1.60	$1,131	Direct
Sep 2, 2025	LUNG Pulmonx Corp	Sale(S)	2,462	$1.60	$3,939	Direct
Sep 2, 2025	LUNG Pulmonx Corp	Sale(S)	1,575	$1.60	$2,520	Direct
Sep 2, 2025	LUNG Pulmonx Corp	Sale(S)	1,799	$1.60	$2,878	Direct
Jun 2, 2025	LUNG Pulmonx Corp	Sale(S)	708	$3.13	$2,216	Direct
Jun 2, 2025	LUNG Pulmonx Corp	Sale(S)	1,799	$3.13	$5,631	Direct
Jun 2, 2025	LUNG Pulmonx Corp	Sale(S)	401	$3.14	$1,259	Direct
Jun 2, 2025	LUNG Pulmonx Corp	Sale(S)	1,576	$3.13	$4,933	Direct

1-25 of 39 transactions

About Rose Geoffrey Beran

Rose Geoffrey Beran (SEC CIK 0001804146) files insider reports with the SEC as Chief Commercial Officer of Pulmonx Corp (LUNG).

Signal8 holds 9 ownership filings by Rose Geoffrey Beran, all Form 4s, filed between Sep 5, 2024 and Sep 3, 2026. Those filings report 39 transactions, from Sep 3, 2024 to Sep 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Rose Geoffrey Beran's filings is in REDWOOD CITY, CA.

Recent filings by Rose Geoffrey Beran

Sep 1, 2026: Open-market sales of LUNG shares (4 lines, Form 4, code S).
Jun 1, 2026: Open-market sales of LUNG shares (4 lines, Form 4, code S).
Mar 2, 2026: Grant or award of LUNG shares (Form 4, code A).
Mar 2, 2026: Open-market sales of LUNG shares (4 lines, Form 4, code S).
Dec 1, 2025: Open-market sales of LUNG shares (4 lines, Form 4, code S).

Other insiders filing for Pulmonx Corp (LUNG)

French Glendon E. III, President and CEO
Radhakrishnan Srikanth, Chief Science & Techn. Officer
Lehman David Aaron, General Counsel
Burns Thomas William, Director
Ferrari Richard, Director
Florin Daniel P, Director

How to read Form 4 transaction codes